Biotech · Private company
NewLink Genetics Corporation
Track this companyFree. Adds NewLink Genetics Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials250 recruiting or active
Pipeline programs48From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline48
- 5FU ChemoradiationPhase 3 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 3 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- HyperAcute-Pancreas ImmunotherapyPhase 3 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 2 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- Camptothecin (CPT) conjugated to a linear, cyclodextrin-based polymerPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- CRLX101Phase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- CRLX301Phase 2 · Advanced Solid Tumor MalignancyClinicalTrials.gov · fetched Nov 12, 2026
- Drug: Hyperacute Lung Cancer Cell VaccinePhase 2 · Non-small Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Metastatic Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- HyperAcute - Breast cancer vaccinePhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- HyperAcute-Lung Cancer VaccinePhase 2 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- HyperAcute-Melanoma VaccinePhase 2 · Malignant MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- HyperAcute-Pancreatic Cancer VaccinePhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- HyperAcute-Prostate Cancer VaccinePhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- HyperAcute(R)-Pancreatic Cancer VaccinePhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- HyperAcute®-Melanoma (HAM) ImmunotherapyPhase 2 · Stage IV MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- IndoximodPhase 2 · Metastatic Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- IndoximodPhase 2 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- IndoximodPhase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- IndoximodPhase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- IpilimumabPhase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- IpilimumabPhase 2 · Stage IV MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- IT-101 (12mg/m2/dose)Phase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- IT-101 (15mg/m2/dose)Phase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- Nab-PaclitaxelPhase 2 · Metastatic Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Stage IV MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Stage IV MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Stereotactic RadiationPhase 2 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 2 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- 1-methyl-D-tryptophanPhase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Conformal RadiationPhase 1 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- CytarabinePhase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 1 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- EtoposidePhase 1 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- HyperAcute®-Renal (HAR) ImmunotherapyPhase 1 · Metastatic Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- IdarubicinPhase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- IndoximodPhase 1 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Indoximod FreebasePhase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Indoximod HCL F1Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Indoximod HCL F2Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- NLG802Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Tergenpumatucel-LPhase 1 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab for Subjects With Unresectable or Metastatic MelanomaPHASE2 · TERMINATED · started Dec 8, 2017ClinicalTrials.gov NCT03301636 · fetched Nov 12, 2026
- Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) ImmunotherapyTERMINATED · started Sep 1, 2017ClinicalTrials.gov NCT03165188 · fetched Nov 12, 2026
- NLG802 Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid TumorsPHASE1 · COMPLETED · started Jun 29, 2017ClinicalTrials.gov NCT03164603 · fetched Nov 12, 2026
- A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid LeukemiaPHASE1 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02835729 · fetched Nov 12, 2026
- Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung CancerPHASE1 · TERMINATED · started Jan 1, 2016ClinicalTrials.gov NCT02460367 · fetched Nov 12, 2026
- Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain TumorsPHASE1 · COMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02502708 · fetched Nov 12, 2026
- A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal CancerPHASE1_PHASE2 · TERMINATED · started Jul 1, 2015ClinicalTrials.gov NCT02389985 · fetched Nov 12, 2026
- Immunotherapy Study for Metastatic Renal Cell CancerPHASE1 · COMPLETED · started May 1, 2015ClinicalTrials.gov NCT02035358 · fetched Nov 12, 2026
- Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid TumorsPHASE1_PHASE2 · TERMINATED · started Apr 1, 2015ClinicalTrials.gov NCT02380677 · fetched Nov 12, 2026
- Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic CancerPHASE1_PHASE2 · COMPLETED · started Aug 1, 2014ClinicalTrials.gov NCT02077881 · fetched Nov 12, 2026
- Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic MelanomaPHASE1_PHASE2 · COMPLETED · started Jul 1, 2014ClinicalTrials.gov NCT02073123 · fetched Nov 12, 2026
- Immunotherapy Study for Patients With Stage IV MelanomaPHASE2 · TERMINATED · started Jun 1, 2014ClinicalTrials.gov NCT02054520 · fetched Nov 12, 2026
- Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain TumorsPHASE1_PHASE2 · COMPLETED · started Mar 1, 2014ClinicalTrials.gov NCT02052648 · fetched Nov 12, 2026
- Immunotherapy Study for Surgically Resected Pancreatic CancerPHASE3 · COMPLETED · started Apr 1, 2010ClinicalTrials.gov NCT01072981 · fetched Nov 12, 2026
- Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.PHASE2 · WITHDRAWN · started Sep 1, 2008ClinicalTrials.gov NCT00753740 · fetched Nov 12, 2026
- IDO Inhibitor Study for Relapsed or Refractory Solid TumorsPHASE1 · TERMINATED · started Aug 1, 2008ClinicalTrials.gov NCT00739609 · fetched Nov 12, 2026
- Low Dose Vaccine Study for Surgically Resected Pancreatic CancerPHASE2 · TERMINATED · started Jan 1, 2008ClinicalTrials.gov NCT00614601 · fetched Nov 12, 2026
- Vaccine Study for Surgically Resected Pancreatic CancerPHASE2 · COMPLETED · started Dec 1, 2007ClinicalTrials.gov NCT00569387 · fetched Nov 12, 2026
- Vaccine Maintenance Treatment for Non-Small Cell Lung CancerPHASE2 · TERMINATED · started Jan 1, 2007ClinicalTrials.gov NCT00420732 · fetched Nov 12, 2026
- Study of CRLX101 (NLG207) in the Treatment of Advanced Solid TumorsPHASE1_PHASE2 · COMPLETED · started May 1, 2006ClinicalTrials.gov NCT00333502 · fetched Nov 12, 2026
- Vaccine Treatment for Advanced Malignant MelanomaPHASE1_PHASE2 · COMPLETED · started Mar 1, 2006ClinicalTrials.gov NCT00300612 · fetched Nov 12, 2026
- Vaccine Treatment for Surgically Resected Pancreatic CancerPHASE1_PHASE2 · COMPLETED · started Nov 1, 2005ClinicalTrials.gov NCT00255827 · fetched Nov 12, 2026
- Vaccine Treatment for Hormone Refractory Prostate CancerPHASE1_PHASE2 · COMPLETED · started Mar 1, 2005ClinicalTrials.gov NCT00105053 · fetched Nov 12, 2026
- Vaccine Treatment for Advanced Breast CancerPHASE1_PHASE2 · TERMINATED · started Aug 1, 2004ClinicalTrials.gov NCT00090480 · fetched Nov 12, 2026
- Vaccine Treatment for Advanced Non-Small Cell Lung CancerPHASE1_PHASE2 · COMPLETED · started Nov 1, 2003ClinicalTrials.gov NCT00073398 · fetched Nov 12, 2026